SKIN |
Beauty Health Co |
Aug 12, 2024 |
1 |
$43.7K |
4 |
Aug 13, 2024 |
Director, Chairman |
BLCO |
Bausch & Lomb Corp |
Aug 5, 2024 |
2 |
$505K |
4 |
Aug 7, 2024 |
CEO and Chairman of the Board, Director |
SPRY |
ARS Pharmaceuticals, Inc. |
Jun 20, 2024 |
1 |
$0 |
4 |
Jun 24, 2024 |
Director |
BLCO |
Bausch & Lomb Corp |
Feb 28, 2024 |
2 |
$0 |
4 |
Mar 1, 2024 |
CEO and Chair, Director |
SKIN |
Beauty Health Co |
Aug 16, 2023 |
1 |
$362K |
4 |
Aug 17, 2023 |
Director, Chairman |
SPRY |
ARS Pharmaceuticals, Inc. |
Jun 27, 2023 |
1 |
$0 |
4 |
Jun 28, 2023 |
Director |
SKIN |
Beauty Health Co |
Jun 14, 2023 |
1 |
$0 |
4 |
Jun 16, 2023 |
Director, Chairman |
BLCO |
Bausch & Lomb Corp |
Mar 6, 2023 |
0 |
$0 |
3/A |
Mar 6, 2023 |
CEO and Chair, Director |
CSCO |
CISCO SYSTEMS, INC. |
Dec 8, 2022 |
1 |
$0 |
4 |
Dec 12, 2022 |
Director |
SPRY |
ARS Pharmaceuticals, Inc. |
Nov 8, 2022 |
2 |
$0 |
4 |
Nov 10, 2022 |
Director |
SPRY |
ARS Pharmaceuticals, Inc. |
Nov 8, 2022 |
0 |
$0 |
3 |
Nov 10, 2022 |
Director |
BBIO |
BridgeBio Pharma, Inc. |
Jun 22, 2022 |
1 |
$0 |
4 |
Jun 24, 2022 |
Director |
SKIN |
Beauty Health Co |
Mar 31, 2022 |
6 |
-$322K |
4 |
Jul 10, 2024 |
Director, Chairman |
SKIN |
Beauty Health Co |
Feb 4, 2022 |
2 |
$0 |
4 |
Feb 8, 2022 |
Director, Executive Chairman |
SKIN |
Beauty Health Co |
Jan 27, 2022 |
1 |
-$83.4K |
4 |
Jan 31, 2022 |
Director, Executive Chairman |
BBIO |
BridgeBio Pharma, Inc. |
Dec 29, 2021 |
1 |
$255K |
4 |
Jan 3, 2022 |
Director |
CSCO |
CISCO SYSTEMS, INC. |
Dec 13, 2021 |
1 |
$0 |
4 |
Dec 15, 2021 |
Director |
SKIN |
Beauty Health Co |
Sep 10, 2021 |
2 |
$0 |
4 |
Sep 14, 2021 |
Director, Executive Chairman |
BBIO |
BridgeBio Pharma, Inc. |
Jun 17, 2021 |
1 |
$0 |
4 |
Jun 22, 2021 |
Director |
SKIN |
Beauty Health Co |
May 14, 2021 |
2 |
$0 |
4 |
May 18, 2021 |
Director, Executive Chairman, 10%+ Owner |
SKIN |
Beauty Health Co |
May 6, 2021 |
3 |
$0 |
4 |
May 10, 2021 |
Executive Chairman, Director |
SKIN |
Beauty Health Co |
Oct 2, 2020 |
1 |
$0 |
4 |
May 18, 2021 |
Director, Executive Chairman, 10%+ Owner |